Nordson (NDSN) 10-Q 5 Sep 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jul. 31, 2019	Aug. 30, 2019
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Trading Symbol	NDSN
Entity Registrant Name	NORDSON CORP
Entity Central Index Key	0000072331
Current Fiscal Year End Date	--10-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		57,490,343
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	0-7977
Entity Tax Identification Number	34-0590250
Entity Address, Address Line One	28601 Clemens Road
Entity Address, City or Town	Westlake
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44145
City Area Code	440
Local Phone Number	892-1580
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Shares, without par value
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	OH
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Income Statement [Abstract]
Sales	$ 559,746	$ 581,243	$ 1,608,775	$ 1,685,373
Operating costs and expenses:
Cost of sales	257,123	260,767	735,647	756,909
Selling and administrative expenses	172,347	182,934	529,675	542,680
Total operating costs and expenses	429,470	443,701	1,265,322	1,299,589
Operating profit	130,276	137,542	343,453	385,784
Other income (expense):
Interest expense	(11,500)	(13,765)	(36,238)	(37,210)
Interest and investment income	511	356	1,153	865
Other - net	210	(1,438)	(4,546)	(5,107)
Total other income (expense)	(10,779)	(14,847)	(39,631)	(41,452)
Income before income taxes	119,497	122,695	303,822	344,332
Income taxes	25,569	27,811	69,404	53,658
Net income	$ 93,928	$ 94,884	$ 234,418	$ 290,674
Average common shares	57,395	58,053	57,463	57,931
Incremental common shares attributable to outstanding stock options, restricted stock, and deferred stock-based compensation	722	859	720	979
Average common shares and common share equivalents	58,117	58,912	58,183	58,910
Basic earnings per share	$ 1.64	$ 1.63	$ 4.08	$ 5.02
Diluted earnings per share	$ 1.62	$ 1.61	$ 4.03	$ 4.93

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 93,928	$ 94,884	$ 234,418	$ 290,674
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(7,172)	(26,361)	227	(7,063)
Amortization of prior service cost and net actuarial losses, net of tax	2,378	2,796	5,328	7,118
Total other comprehensive income (loss)	(4,794)	(23,565)	5,555	55
Total comprehensive income	$ 89,134	$ 71,319	$ 239,973	$ 290,729

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (UNAUDITED) - USD ($) $ in Thousands	Jul. 31, 2019	Oct. 31, 2018
Current assets:
Cash and cash equivalents	$ 147,845	$ 95,678
Receivables - net	499,981	491,423
Inventories - net	282,614	264,477
Prepaid expenses and other current assets	50,300	32,524
Total current assets	980,740	884,102
Property, plant and equipment - net	392,034	386,666
Goodwill	1,613,476	1,608,018
Intangible assets - net	459,027	499,741
Deferred income taxes	11,287	9,780
Other assets	34,974	32,705
Total assets	3,491,538	3,421,012
Current liabilities:
Accounts payable	85,565	83,590
Income taxes payable	745	19,319
Accrued liabilities	138,909	175,085
Customer advanced payments	45,523	38,997
Current maturities of long-term debt	168,734	28,734
Current obligations under capital leases	4,746	4,555
Total current liabilities	444,222	350,280
Long-term debt	1,179,872	1,285,357
Deferred income taxes	102,429	100,704
Pension obligations	93,913	113,222
Postretirement obligations	71,310	70,154
Other long-term liabilities	52,904	50,554
Shareholders' equity:
Common shares	12,253	12,253
Capital in excess of stated value	470,951	446,555
Retained earnings	2,666,797	2,488,375
Accumulated other comprehensive loss	(173,759)	(179,314)
Common shares in treasury, at cost	(1,429,354)	(1,317,128)
Total shareholders' equity	1,546,888	1,450,741
Total liabilities and shareholders' equity	$ 3,491,538	$ 3,421,012

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (UNAUDITED) - USD ($) $ in Thousands	Total	Common Shares [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Common Shares in Treasury, At Cost [Member]
Balance at Oct. 31, 2017	$ 1,155,493	$ 12,253	$ 412,785	$ 2,164,597	$ (134,435)	$ (1,299,707)
Shares issued under company stock and employee benefit plans	10,305		6,526			3,779
Stock-based compensation	6,987		6,987
Purchase of treasury shares, value	(4,989)					(4,989)
Dividends declared	(17,321)			(17,321)
Net income	104,555			104,555
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	38,582				38,582
Defined benefit pension and post-retirement plans adjustment	1,509				1,509
Balance at Jan. 31, 2018	1,295,121	12,253	426,298	2,251,831	(94,344)	(1,300,917)
Balance at Oct. 31, 2017	1,155,493	12,253	412,785	2,164,597	(134,435)	(1,299,707)
Net income	290,674
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(7,063)
Balance at Jul. 31, 2018	1,422,916	12,253	440,442	2,403,162	(134,380)	(1,298,561)
Balance at Jan. 31, 2018	1,295,121	12,253	426,298	2,251,831	(94,344)	(1,300,917)
Shares issued under company stock and employee benefit plans	5,291		3,645			1,646
Stock-based compensation	5,127		5,127
Purchase of treasury shares, value	(16)					(16)
Dividends declared	(17,376)			(17,376)
Net income	91,235			91,235
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(19,284)				(19,284)
Defined benefit pension and post-retirement plans adjustment	2,812				2,812
Balance at Apr. 30, 2018	1,362,910	12,253	435,070	2,325,690	(110,816)	(1,299,287)
Shares issued under company stock and employee benefit plans	1,757		973			784
Stock-based compensation	4,399		4,399
Purchase of treasury shares, value	(58)					(58)
Dividends declared	(17,412)			(17,412)
Net income	94,884			94,884
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(26,361)				(26,361)
Defined benefit pension and post-retirement plans adjustment	2,797				2,797
Balance at Jul. 31, 2018	1,422,916	12,253	440,442	2,403,162	(134,380)	(1,298,561)
Balance at Oct. 31, 2018	1,450,741	12,253	446,555	2,488,375	(179,314)	(1,317,128)
Shares issued under company stock and employee benefit plans	3,607		1,016			2,591
Stock-based compensation	4,359		4,359
Purchase of treasury shares, value	(107,667)					(107,667)
Dividends declared	(20,210)			(20,210)
Net income	48,567			48,567
Impact of adoption of ASU 2014-09 (See Note 2)	4,329			4,329
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	16,463				16,463
Defined benefit pension and post-retirement plans adjustment	1,352				1,352
Balance at Jan. 31, 2019	1,401,541	12,253	451,930	2,521,061	(161,499)	(1,422,204)
Balance at Oct. 31, 2018	1,450,741	12,253	446,555	2,488,375	(179,314)	(1,317,128)
Net income	234,418
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	227
Balance at Jul. 31, 2019	1,546,888	12,253	470,951	2,666,797	(173,759)	(1,429,354)
Balance at Jan. 31, 2019	1,401,541	12,253	451,930	2,521,061	(161,499)	(1,422,204)
Shares issued under company stock and employee benefit plans	10,847		8,116			2,731
Stock-based compensation	4,869		4,869
Purchase of treasury shares, value	(10,422)					(10,422)
Dividends declared	(20,029)			(20,029)
Net income	91,923			91,923
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(9,064)				(9,064)
Defined benefit pension and post-retirement plans adjustment	1,598				1,598
Balance at Apr. 30, 2019	1,471,263	12,253	464,915	2,592,955	(168,965)	(1,429,895)
Shares issued under company stock and employee benefit plans	2,821		2,245			576
Stock-based compensation	3,791		3,791
Purchase of treasury shares, value	(35)					(35)
Dividends declared	(20,086)			(20,086)
Net income	93,928			93,928
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(7,172)				(7,172)
Defined benefit pension and post-retirement plans adjustment	2,378				2,378
Balance at Jul. 31, 2019	$ 1,546,888	$ 12,253	$ 470,951	$ 2,666,797	$ (173,759)	$ (1,429,354)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (UNAUDITED) (Parenthetical) - $ / shares shares in Thousands	3 Months Ended
	Jul. 31, 2019	Apr. 30, 2019	Jan. 31, 2019	Jul. 31, 2018	Apr. 30, 2018	Jan. 31, 2018
Statement Of Stockholders Equity [Abstract]
Purchase of treasury shares, shares	261	78,957	901,545	445	120	34,645
Dividends declared per share	$ 0.35	$ 0.35	$ 0.35	$ 0.30	$ 0.30	$ 0.30

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018
Cash flows from operating activities:
Net income	$ 234,418	$ 290,674
Depreciation and amortization	83,331	81,037
Non-cash stock compensation	13,019	16,513
Deferred income taxes	(1,828)	(47,563)
Other non-cash expense	2,455	1,040
Loss on sale of property, plant and equipment	1,053	741
Changes in operating assets and liabilities	(96,017)	485
Net cash provided by operating activities	236,431	342,927
Cash flows from investing activities:
Additions to property, plant and equipment	(46,002)	(45,972)
Proceeds from sale of property, plant and equipment	1,037	299
Acquisition of businesses, net of cash acquired	(12,110)	(45,364)
Equity investments	(844)
Net cash used in investing activities	(57,919)	(91,037)
Cash flows from financing activities:
Proceeds from short-term borrowings		996
Repayment of short-term borrowings		(1,006)
Proceeds from long-term debt	184,892	474,372
Repayment of long-term debt	(148,883)	(503,765)
Repayment of capital lease obligations	(4,442)	(4,241)
Issuance of common shares	17,275	17,352
Purchase of treasury shares	(118,124)	(5,063)
Dividends paid	(60,325)	(52,109)
Net cash used in financing activities	(129,607)	(73,464)
Effect of exchange rate changes on cash	3,262	(2,007)
Increase in cash and cash equivalents	52,167	176,419
Cash and cash equivalents:
Beginning of year	95,678	90,383
End of period	$ 147,845	$ 266,802

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Jul. 31, 2019
Accounting Policies [Abstract]
Significant Accounting Policies	1. Significant accounting policies Basis of presentation Basis of consolidation Use of estimates Earnings per share

Revenue Recognition

Revenue Recognition	9 Months Ended
	Jul. 31, 2019
Revenue From Contract With Customer [Abstract]
Revenue Recognition	2. Revenue recognition Adoption of new accounting standard: On November 1, 2018, we adopted ASU 2014-09 (“Topic 606”) using the modified retrospective method applied to those contracts which were not completed as of November 1, 2018. Results for reporting periods beginning after November 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting. The cumulative impact of adopting Topic 606 as of November 1, 2018 did not have a material impact to the Consolidated Financial Statements. The Company does not expect the impact of the adoption of Topic 606 to be material to the Consolidated Financial Statements on an ongoing basis. Accounting policy: A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and continues to primarily be recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2019 and October 31, 2018 were not material. However, for certain contracts related to the sale of customer-specific product within our Advanced Technology Systems segment, there was a change in revenue recognition upon adoption of the new revenue standard. Previously, these contracts were recognized at the point in time when the shipping terms were satisfied. Under the new revenue standard, we now recognize revenue for these contracts over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at July 31, 2019. Revenue recognized over time is not material to our overall Consolidated Financial Statements. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Sales, value add, and other taxes we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling, general and administrative expenses in our Consolidated Statements of Income. We offer assurance type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term. See Note 11 for details on our warranties. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, therefore, are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. See Note 12 for details on our operating segments.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	9 Months Ended
	Jul. 31, 2019
Accounting Changes And Error Corrections [Abstract]
Recently Issued Accounting Standards	3 . Recently issued accounting standards New accounting guidance adopted: In March 2017, the FASB issued a new standard which requires the presentation of the service cost component of the net periodic benefit cost in the same income statement line item as other employee compensation costs arising from services rendered during the period. All other components of net periodic benefit cost are presented below operating income. Additionally, only the service cost component will be eligible for capitalization in assets. We adopted the standard beginning November 1, 2018. During the three and nine months ended July 31, 2018, the reclassification resulted in an increase in Other expense of $1,966 and $5,780, respectively, a decrease in Cost of sales of $80 and $237, respectively, and a decrease in Selling, general & administrative expenses of $1,886 and $5,543, respectively. New accounting guidance issued and not yet adopted: In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which requires a lessee to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with a lease term of more than twelve months. Leases will be classified as either financing or operating, with classification affecting the recognition, measurement and presentation of expenses and cash flows arising from a lease. While the Company is currently evaluating the impact that this new guidance will have on its consolidated financial statements, it is expected that the primary impact upon adoption will be the recognition, on a discounted basis, of the Company's minimum commitments under noncancelable operating leases as right of use assets and lease liabilities on the consolidated balance sheets. It is expected that this could result in a substantial increase in assets and liabilities on the consolidated balance sheets. We will adopt the new standard on the required effective date of November 1, 2019 using the transition option, established by ASU 2018-11, Leases (Topic 842), Targeted Improvements (ASU 2018-11). This transition option was released by the FASB to reduce the cost and complexity associated with reflecting the new standard in prior periods presented. We will also elect the practical expedient package related to the identification of leases in contracts, lease classification, and accounting for initial direct costs whereby prior conclusions do not have to be reassessed for leases that commenced before the effective date. As we will not reassess such conclusions, we do not plan to adopt the practical expedient to use hindsight to determine the likelihood of whether a lease will be extended, terminated or whether a purchase option will be exercised. A cross-functional implementation team is continuing to validate data within the enterprise-wide lease management system to assess functionality as well as identifying the appropriate changes to business processes and controls to support recognition and disclosure under the new standard. In June 2016, the FASB issued a new standard that changes the impairment model for most financial instruments. Current guidance requires the recognition of credit losses based on an incurred loss impairment methodology that reflects losses once the losses are probable. We will be required to use a current expected credit loss model that will immediately recognize an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of this update, including trade receivables. ASU 2016-13 does not prescribe a specific method to make an estimate so the application will require judgment and should consider historical information, current information, reasonable and supportable forecasts, and includes estimates of prepayment. This guidance will become effective for us on November 1, 2020. We are currently assessing the impact this standard will have on the Consolidated Financial Statements. In August 2018, the FASB issued a new standard which removes, modifies, and adds certain disclosure requirements on fair value measurements. The guidance removes disclosure requirements pertaining to the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. For investments in certain entities that calculate net asset value, an entity is required to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. In addition, the amendment clarifies that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date. The guidance adds disclosure requirements for changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. It will be effective for us beginning November 1, 2020. Early adoption is permitted. We are currently assessing the impact this standard will have on our Consolidated Financial Statements. In August 2018, the FASB issued a new standard which addresses defined benefit plans. The amendments modify the following disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans: the amounts in accumulated other comprehensive income expected to be recognized as components of net period benefit cost over the next fiscal year, amount and timing of plan assets expected to be returned to the employer, related party disclosure about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan, and the effects of a one-percentage point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligation for postretirement health care benefits are removed. A disclosure requirement was added for the explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Additionally, the standard clarifies disclosure requirement surrounding the projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets and the accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets. It will be effective for us beginning November 1, 2020. Early adoption is permitted. We are currently assessing the impact this standard will have on our Consolidated Financial Statements.

Acquisitions

Acquisitions	9 Months Ended
	Jul. 31, 2019
Business Combinations [Abstract]
Acquisitions	4 . Acquisitions Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Consolidated Statements of Income. 2019 acquisition On July 1, 2019, we purchased certain assets of Optical Control GmbH & Co. KG (“Optical”), a Nuremberg, Germany designer and developer of high speed, fully automatic counting systems utilizing x-ray technology. This transaction was not material to our Consolidated Financial Statements. We recorded the acquisition of Optical based on the fair value of the assets acquired and the liabilities assumed. Goodwill associated with this acquisition is tax deductible. This acquisition is being reported in our Advanced Technology Systems segment. As of July 31, 2019, the purchase price allocations remain preliminary as we complete our assessments of income taxes, intangible assets and certain reserves. 2018 acquisitions On October 17, 2018, we purchased 100 percent of the outstanding shares of Cladach Nua Teoranta (“Clada”), a Galway, Ireland designer and developer primarily focused on medical balloons and balloon catheters. Clada’s technologies are used in key applications such as angioplasty and the treatment of vascular disease. We acquired Clada for an aggregate purchase price of $5,236, which included an earn-out liability of $1,131. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $3,776 and identifiable intangible assets of $697 were recorded. The identifiable intangible assets consist primarily of $58 of customer relationships (amortized over 6 years), $70 of tradenames (amortized over 9 years), $499 of technology (amortized over 7 years) and $70 of non-compete agreements (amortized over 3 years). Goodwill associated with this acquisition is not tax deductible. This acquisition is being reported in our Advanced Technology Systems segment. As of July 31, 2019, the purchase price allocations remain preliminary as we complete our assessments of income taxes. On January 2, 2018, we purchased 100 percent of the outstanding shares of Sonoscan, Inc. (“Sonoscan”), an Elk Grove Village, Illinois leading designer and manufacturer of acoustic microscopes and sophisticated acoustic micro imaging systems used in a variety of microelectronic, automotive, aerospace and industrial electronic assembly applications. We acquired Sonoscan for an aggregate purchase price of $46,018, net of $655 of cash. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $22,775 and identifiable intangible assets of $7,910 were recorded. The identifiable intangible assets consist primarily of $1,700 of customer relationships (amortized over 7 years), $3,300 of tradenames (amortized over 11 years), $2,500 of technology (amortized over 7 years) and $410 of non-compete agreements (amortized over 5 years). Goodwill associated with this acquisition is tax deductible. This acquisition is being reported in our Advanced Technology Systems segment. As of July 31, 2019, the purchase price allocations are complete.

Inventories

Inventories	9 Months Ended
	Jul. 31, 2019
Inventory Disclosure [Abstract]
Inventories	5 . At July 31, 2019 and October 31, 2018, inventories consisted of the following: July 31, 2019 October 31, 2018 Raw materials and component parts $ 101,203 $ 112,823 Work-in-process 45,234 47,126 Finished goods 182,770 148,618 329,207 308,567 Obsolescence and other reserves (40,231 ) (37,545 ) LIFO reserve (6,362 ) (6,545 ) $ 282,614 $ 264,477

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Jul. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	6 . Goodwill and other intangible assets Changes in the carrying amount of goodwill for the nine months ended July 31, 2019 by operating segment are as follows: Adhesive Dispensing Systems Advanced Technology Systems Industrial Coating Systems Total Balance at October 31, 2018 $ 388,991 $ 1,194,969 $ 24,058 $ 1,608,018 Acquisitions — 9,168 — 9,168 Currency effect (2,278 ) (1,432 ) — (3,710 ) Balance at July 31, 2019 $ 386,713 $ 1,202,705 $ 24,058 $ 1,613,476 Accumulated impairment losses, which were recorded in 2009, were $232,789 at July 31, 2019 and October 31, 2018. Of these losses, $229,173 related to the Advanced Technology Systems segment, and $3,616 related to the Industrial Coating Systems segment. Information regarding our intangible assets subject to amortization is as follows: July 31, 2019 Carrying Accumulated Amortization Net Customer relationships $ 479,033 $ 164,172 $ 314,861 Patent/technology costs 153,557 67,997 85,560 Trade name 96,910 39,575 57,335 Non-compete agreements 11,522 10,254 1,268 Other 1,399 1,396 3 Total $ 742,421 $ 283,394 $ 459,027 October 31, 2018 Carrying Accumulated Amortization Net Book Value Customer relationships $ 480,404 $ 137,640 $ 342,764 Patent/technology costs 153,602 59,845 93,757 Trade name 96,433 34,768 61,665 Non-compete agreements 11,469 9,919 1,550 Other 1,386 1,381 5 Total $ 743,294 $ 243,553 $ 499,741 Amortization expense for the three months ended July 31, 2019 and 2018 was $13,903 and $14,036, respectively. Amortization expense for the nine months ended July 31, 2019 and 2018 was $41,665 and $42,097, respectively.

Pension and Other Postretiremen

Pension and Other Postretirement Plans	9 Months Ended
	Jul. 31, 2019
Compensation And Retirement Disclosure [Abstract]
Pension and Other Postretirement Plans	7 . Pension and other postretirement plans The components of net periodic pension cost for the three and nine months ended July 31, 2019 and 2018 were: U.S. International Three Months Ended 2019 2018 2019 2018 Service cost $ 3,740 $ 3,314 $ 484 $ 505 Interest cost 4,736 3,704 416 413 Expected return on plan assets (5,908 ) (5,491 ) (397 ) (379 ) Amortization of prior service credit (16 ) (5 ) (76 ) (80 ) Amortization of net actuarial loss 1,938 2,353 424 527 Total benefit cost $ 4,490 $ 3,875 $ 851 $ 986 U.S. International Nine Months Ended 2019 2018 2019 2018 Service cost $ 10,895 $ 9,940 $ 1,454 $ 1,532 Interest cost 13,726 11,113 1,262 1,257 Expected return on plan assets (17,506 ) (16,472 ) (1,204 ) (1,152 ) Amortization of prior service credit (46 ) (17 ) (228 ) (242 ) Amortization of net actuarial loss 5,026 7,059 1,280 1,604 Total benefit cost $ 12,095 $ 11,623 $ 2,564 $ 2,999 The components of other postretirement benefit cost for the three and nine months ended July 31, 2019 and 2018 were: U.S. International Three Months Ended 2019 2018 2019 2018 Service cost $ 70 $ 172 $ 3 $ 5 Interest cost 698 627 3 5 Amortization of prior service credit (6 ) (24 ) — — Amortization of net actuarial (gain) loss 162 264 (5 ) (5 ) Total benefit cost $ 924 $ 1,039 $ 1 $ 5 U.S. International Nine Months Ended 2019 2018 2019 2018 Service cost $ 401 $ 528 $ 13 $ 15 Interest cost 2,195 1,922 15 15 Amortization of prior service credit (20 ) (74 ) — — Amortization of net actuarial (gain) loss 467 809 (22 ) (15 ) Total benefit cost $ 3,043 $ 3,185 $ 6 $ 15 The components of net periodic pension cost other than service cost are included in Other – net in our Consolidated Statements of Income.

Income Taxes

Income Taxes	9 Months Ended
	Jul. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	8 . Income taxes We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rates for the three and nine months ended July 31, 2019 were 21.4% and 22.8%, respectively. The effective tax rates for the three and nine months ended July 31, 2018 were 22.7% and 15.6%. The effective tax rate for the nine months ended July 31, 2019 On December 22, 2017, the Act was enacted into law which significantly revised U.S. tax law. It reduced the U.S. federal corporate income tax rate from 35% to 21%. We have an October 31 fiscal year-end, therefore the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of 23.3% for our fiscal year ended October 31, 2018, and 21% for subsequent fiscal years. The statutory tax rate of 21.0% was applied to earnings in the current quarter. Subsequent to the enactment of the Act, the SEC staff issued SAB 118, which provided a measurement period of up to one year after the enactment date for companies to finalize the recognition of the income tax effects of the Act. As of January 31, 2019, our provisional accounting for the effects of the Act was complete. During the nine months ended July 31, 2019, and within the one year measurement period provided by SAB 118, a discrete tax expense of $4,866 was recorded to the provisional amounts recognized in 2018 due to changes in interpretations and assumptions and the finalization of estimates. During the nine months ended July 31, 2018, we provisionally recorded a discrete tax benefit of $22,089. In March 2016, the FASB issued a new standard which simplifies the accounting for share-based payment transactions. This guidance required that excess tax benefits and tax deficiencies be recognized as income tax expense or benefit in the Consolidated Statements of Income rather than as additional paid-in capital. As a result, our income tax provision included a discrete tax benefit of $210 and $3,227 for the three and nine months ended July 31, 2019, respectively. Our income tax provision for the three and nine months ended July 31, 2018 included a discrete tax benefit of $544 and $7,494, respectively. During the three months ended July 31, 2019 and July 31, 2018, we recorded a favorable adjustment to unrecognized tax benefits of $858 and $1,041, respectively.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jul. 31, 2019
Equity [Abstract]
Accumulated Other Comprehensive Loss	9 . Accumulated other comprehensive loss The components of accumulated other comprehensive loss, including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated translation postretirement benefit other comprehensive adjustments plan adjustments loss Balance at October 31, 2018 $ (57,042 ) $ (122,272 ) $ (179,314 ) Amortization of prior service costs and net actuarial losses, net of tax of $(1,670) — 5,328 5,328 Foreign currency translation adjustments 227 — 227 Balance at July 31, 2019 $ (56,815 ) $ (116,944 ) $ (173,759 )

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jul. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	10 . Stock-based compensation During the 2018 Annual Meeting of Shareholders, our shareholders approved the Amended and Restated 2012 Stock Incentive and Award Plan (the “2012 Plan”). The 2012 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 4,525 common shares are available for grant under the 2012 Plan. Stock Options Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25 percent per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination (or at any time prior to December 28, 2017) fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $2,525 and $2,479 in the three months ended July 31, 2019 and 2018, respectively. Corresponding amounts for the nine months ended July 31, 2019 and 2018 were $7,583 and $7,550, respectively. The following table summarizes activity related to stock options for the nine months ended July 31, 2019: Number of Options Weighted-Average Exercise Price Per Share Aggregate Intrinsic Value Weighted Average Remaining Term Outstanding at October 31, 2018 1,885 $ 85.33 Granted 348 $ 124.89 Exercised (289 ) $ 59.81 Forfeited or expired (21 ) $ 121.19 Outstanding at July 31, 2019 1,923 $ 95.92 $ 87,950 6.7 years Vested or expected to vest at July 31, 2019 1,907 $ 95.68 $ 87,671 6.7 years Exercisable at July 31, 2019 1,030 $ 78.98 $ 64,554 5.4 years As of July 31, 2019, there was $10,551 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.4 years. The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine months ended July 31, 2019 July 31, 2018 Expected volatility 24.1%-24.5% 24.0%-26.7% Expected dividend yield 1.04% 0.97% Risk-free interest rate 2.84%-2.95% 2.09%-2.20% Expected life of the option (in years) 5.3-6.2 5.4-6.2 The weighted-average expected volatility used to value the 2019 and 2018 options was 24.3% and 25.0%, respectively. Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued. The weighted average grant date fair value of stock options granted during the nine months ended July 31, 2019 and 2018 was $31.74 and $31.42, respectively. The total intrinsic value of options exercised during the three months ended July 31, 2019 and 2018 was $2,449 and $2,971, respectively. The total intrinsic value of options exercised during the nine months ended July 31, 2019 and 2018 was $21,770 and $32,715, respectively. Cash received from the exercise of stock options for the nine months ended July 31, 2019 and 2018 was $17,275 and $17,352, respectively. Restricted Shares and Restricted Share Units We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. For employee recipients, in the event of termination of employment due to early retirement with the consent of the Company, restricted shares granted within 12 months prior to termination are forfeited, and other restricted shares vest on a pro-rata basis. In the event of termination of employment due to normal retirement at age 65, restricted shares granted within 12 months prior to termination are forfeited, and, for other restricted shares, the restriction period will lapse and the shares will vest and be transferable. For restricted shares granted within 12 months prior to termination (or at any time prior to December 28, 2017), the restrictions lapse in the event of a recipient’s disability or death. Termination for any other reason prior to the lapse of any restrictions results in forfeiture of the shares. For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units. As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period. The following table summarizes activity related to restricted shares during the nine months ended July 31, 2019: Number of Shares Weighted-Average Grant Date Fair Value Restricted shares at October 31, 2018 53 $ 108.82 Granted 40 $ 131.19 Vested (26 ) $ 97.84 Restricted shares at July 31, 2019 67 $ 126.30 As of July 31, 2019, there was $5,505 of unrecognized compensation cost related to restricted shares. The cost is expected to be amortized over a weighted average period of 1.8 years. The amount charged to expense related to restricted shares during the three months ended July 31, 2019 and 2018 was $898 and $644, respectively. These amounts included common share dividends for the three months ended July 31, 2019 and 2018 of $22 and $17, respectively. For the nine months ended July 31, 2019 and 2018, the amounts charged to expense related to restricted shares were $2,762 and $2,035, respectively. These amounts included common share dividends for the nine months ended July 31, 2019 and 2018 of $58 and $51, respectively. The following table summarizes activity related to restricted share units during the nine months ended July 31, 2019: Number of Units Weighted-Average Grant Date Fair Value Restricted share units at October 31, 2018 0 $ — Granted 8 $ 126.83 Restricted share units at July 31, 2019 8 $ 126.83 As of July 31, 2019, there was $260 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 0.3 years. The amount charged to expense related to restricted share units during each of the three months ended July 31, 2019 and 2018 was $263 and $253, respectively. For the nine months ended July 31, 2019 and 2018, the corresponding amounts were $789 and $758, respectively. Deferred Directors’ Compensation Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared. The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2019: Number of Shares Weighted-Average Grant Date Fair Value Outstanding at October 31, 2018 107 $ 51.24 Dividend equivalents 1 $ 128.35 Outstanding at July 31, 2019 108 $ 51.87 The amount charged to expense related to director deferred compensation for the three months ended July 31, 2019 and 2018 was $38 and $31, respectively. For the nine months ended July 31, 2019 and 2018, the corresponding amounts were $113 and $92, respectively. Performance Share Incentive Awards Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved. The amount of compensation expense is based upon current performance projections for each three-year period and the percentage of the requisite service that has been rendered. The calculations are also based upon the grant date fair value determined using the closing market price of our common shares at the grant date, reduced by the implied value of dividends not to be paid. The per share values were $120.12 for 2019, $123.45 for 2018, and $103.75 and $104.49 per share for 2017. During the three months ended July 31, 2019 and 2018, $15 and $942 was charged to expense, respectively. For the nine months ended July 31, 2019 and 2018, the corresponding amounts were $1,611 and $5,928, respectively. Deferred Compensation Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended July 31, 2019 and 2018 was $74 and $67, respectively. For the nine months ended July 31, 2019 and 2018, the corresponding amounts were $219 and $201, respectively.

Warranties

Warranties	9 Months Ended
	Jul. 31, 2019
Guarantees [Abstract]
Warranties	1 1 . Warranties We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions are adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheet. Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2019 and 2018: July 31, 2019 July 31, 2018 Beginning balance at October 31 $ 12,195 $ 13,377 Accruals for warranties 7,628 8,440 Warranty payments (7,837 ) (9,358 ) Currency effect (78 ) 13 Ending balance $ 11,908 $ 12,472

Operating Segments

Operating Segments	9 Months Ended
	Jul. 31, 2019
Segment Reporting [Abstract]
Operating Segments	1 2 . Operating segments We conduct business across three primary business segments: Adhesive Dispensing Systems, Advanced Technology Systems, and Industrial Coating Systems. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in Note 1, Significant Accounting Policies, of our annual report on Form 10-K for the year ended October 31, 2018. The following table presents information about our segments: Adhesive Advanced Industrial Corporate Total Three months ended July 31, 2019 Net external sales $ 248,983 $ 253,098 $ 57,665 $ — $ 559,746 Operating profit (loss) 77,689 53,562 11,122 (12,097 ) 130,276 Three months ended July 31, 2018 Net external sales $ 244,728 $ 266,595 $ 69,920 $ — $ 581,243 Operating profit (loss) (1) 69,268 67,466 15,633 (14,825 ) 137,542 Nine months ended July 31, 2019 Net external sales $ 697,223 $ 736,850 $ 174,702 $ — $ 1,608,775 Operating profit (loss) 196,594 150,882 33,108 (37,131 ) 343,453 Nine months ended July 31, 2018 Net external sales $ 704,367 $ 789,135 $ 191,871 $ — $ 1,685,373 Operating profit (loss) (1) 193,595 193,649 38,228 (39,688 ) 385,784 (1) A reconciliation of total segment operating income to total consolidated income before income taxes is as follows: Three Months Ended Nine Months Ended July 31, 2019 July 31, 2018 July 31, 2019 July 31, 2018 Total profit for reportable segments $ 130,276 $ 137,542 $ 343,453 $ 385,784 Interest expense (11,500 ) (13,765 ) (36,238 ) (37,210 ) Interest and investment income 511 356 1,153 865 Other-net 210 (1,438 ) (4,546 ) (5,107 ) Income before income taxes $ 119,497 $ 122,695 $ 303,822 $ 344,332 We have significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2019 July 31, 2018 July 31, 2019 July 31, 2018 United States $ 190,460 $ 191,512 $ 551,510 $ 536,164 Americas 47,040 38,911 123,159 112,149 Europe 143,449 150,710 425,650 447,384 Japan 30,488 28,367 89,566 127,266 Asia Pacific 148,309 171,743 418,890 462,410 Total net external sales $ 559,746 $ 581,243 $ 1,608,775 $ 1,685,373

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jul. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	1 3 . Fair value measurements The inputs to the valuation techniques used to measure fair value are classified into the following categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2019 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 4,254 $ — $ 4,254 $ — Total assets at fair value $ 4,254 $ — $ 4,254 $ — Liabilities: Deferred compensation plans (b) $ 11,610 $ — $ 11,610 $ — Foreign currency forward contracts (a) 3,197 — 3,197 — Total liabilities at fair value $ 14,807 $ — $ 14,807 $ — July 31, 2018 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 2,160 $ — $ 2,160 $ — Total assets at fair value $ 2,160 $ — $ 2,160 $ — Liabilities: Deferred compensation plans (b) $ 11,138 $ — $ 11,138 $ — Foreign currency forward contracts (a) 2,399 — 2,399 — Total liabilities at fair value $ 13,537 $ — $ 13,537 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds. The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. 2019 Carrying Amount Fair Value Long-term debt (including current portion) 1,348,606 1,371,640 We used the following methods and assumptions in estimating the fair value of financial instruments: • Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Jul. 31, 2019
Investments All Other Investments [Abstract]
Derivative Financial Instruments	1 4 . Derivative financial instruments We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. For the three months ended July 31, 2019, we recognized net gains of $975 on foreign currency forward contracts and net gains of $407 from the change in fair value of balance sheet positions. For the three months ended July 31, 2018, we recognized gains of $2,042 on foreign currency forward contracts and losses of $1,152 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2019, we recognized gains of $769 on foreign currency forward contracts and gains of $267 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2018, we recognized losses of $529 on foreign currency forward contracts and gains of $451 from the change in fair value of balance sheet positions. The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2019 and 2018: Notional Amounts July 31, 2019 contract amounts: Sell Buy Euro $ 219,910 $ 90,043 British pound 20,542 45,955 Japanese yen 32,560 48,670 Australian dollar 350 7,683 Hong Kong dollar 1,209 136,818 Singapore dollar 782 15,449 Others 3,460 63,388 Total $ 278,813 $ 408,006 Notional Amounts July 31, 2018 contract amounts: Sell Buy Euro $ 239,642 $ 201,296 British pound 41,649 70,644 Japanese yen 22,872 43,591 Australian dollar 185 7,729 Hong Kong dollar 453 118,507 Singapore dollar 613 12,820 Others 3,759 53,868 Total $ 309,173 $ 508,455 We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the nine months ended July 31, 2019 and 2018, there were no significant concentrations of credit risk.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Jul. 31, 2019
Debt Disclosure [Abstract]
Long-Term Debt	1 5 . Long-term debt A summary of long-term debt is as follows: July 31, 2019 October 31, 2018 Revolving credit agreement, due 2024 $ — $ 52,200 Senior notes, due 2020-2025 140,800 156,700 Senior notes, due 2020-2027 92,857 100,000 Senior notes, due 2023-2030 350,000 350,000 Term loan, due 2020-2024 605,000 605,000 Euro loan, due 2021 127,396 16,967 Private shelf facility, due 2020 36,111 36,111 Development loans, due 2019-2026 985 1,086 1,353,149 1,318,064 Less current maturities 168,734 28,734 Less unamortized debt issuance costs 4,543 3,973 Long-term maturities $ 1,179,872 $ 1,285,357 In April 2019, we amended, restated and extended the term of our existing $605,000 term loan facility with a group of banks. The Term Loan Agreement provides for the following term loans in three tranches: $100,000 due in March 2020, $200,000 due in September 2022, and $305,000 due in March 2024. The weighted average interest rate for borrowings under this agreement was 2.98% at July 31, 2019. We were in compliance with all covenants at July 31, 2019. In April 2019, we entered into a $850,000 unsecured, multicurrency credit facility with a group of banks, which amended, restated and extended our existing syndicated revolving credit agreement that was scheduled to expire in February 2020. This facility has a five-year term and includes a $75,000 subfacility for swing-line loans. It expires in April 2024. At July 31, 2019, we had no balances outstanding under this facility, compared to $52,200 outstanding at October 31, 2018. We were in compliance with all covenants at July 31, 2019, and the amount we could borrow under the facility would not have been limited by any debt covenants. In October 2018, we entered into a €150,000 agreement with Bank of America Merrill Lynch International Limited. The interest rate is variable based on the EUR LIBOR rate. The weighted average interest rate at July 31, 2019 was 1.00%. At July 31, 2019, the balance outstanding was €115,000 ($127,396). We were in compliance with all covenants at July 31, 2019. In June 2018, we entered into a Note Purchase Agreement with a group of insurance companies under which we sold $350,000 of Senior Notes to the insurance companies and their affiliates. The notes start to mature in June 2023 and mature through June 2030 and bear interest at fixed rates between 3.71% and 4.17%. We used the proceeds from the sale of the notes to repay approximately $315,000 of the outstanding balance under our existing syndicated revolving credit facility at that time, and the remainder for general corporate purposes. We were in compliance with all covenants at July 31, 2019. We entered into a $150,000 three-year Note Purchase and Private Shelf agreement with New York Life Investment Management LLC in 2011. In 2015, the amount of the facility was increased to $180,000, and in 2016 it was increased to $200,000. Notes issued under the agreement may have a maturity of up to 12 years, with an average life of up to 10 years, and are unsecured. At July 31, 2019 and October 31, 2018, there was $36,111 outstanding under this facility. Existing notes mature between January 2020 and September 2020. The interest rate on each borrowing is fixed based on the market rate at the borrowing date or is variable based upon the LIBOR rate. At July 31, 2019, the amount outstanding under this facility bears interest at fixed rates between 2.21% and 2.56%. This agreement contains customary events of default and covenants related to limitations on indebtedness and the maintenance of certain financial ratios. We were in compliance with all covenants at July 31, 2019, and the amount we could borrow would not have been limited by any debt covenants. In 2012, we entered into a Note Purchase Agreement with a group of insurance companies under which we sold $200,000 of Senior Notes. At July 31, 2019 and October 31, 2018, $140,800 and $156,700, respectively, was outstanding under this agreement. Existing notes mature between July 2020 and July 2025 and bear interest at fixed rates between 2.62% and 3.13%. We were in compliance with all covenants at July 31, 2019. In July 2015, we entered into a Note Purchase Agreement under which $100,000 of Senior Unsecured Notes were purchased primarily by a group of insurance companies. At July 31, 2019 and October 31, 2018, $92,857 and $100,000, respectively, was outstanding under this agreement. Existing notes mature between July 2020 and July 2027 and bear interest at fixed rates of 2.89% and 3.19%. We were in compliance with all covenants at July 31, 2019.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Jul. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation	Basis of presentation
Basis of Consolidation	Basis of consolidation
Use of Estimates	Use of estimates
Earnings Per Share	Earnings per share
Revenue Recognition	Revenue recognition Adoption of new accounting standard: On November 1, 2018, we adopted ASU 2014-09 (“Topic 606”) using the modified retrospective method applied to those contracts which were not completed as of November 1, 2018. Results for reporting periods beginning after November 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting. The cumulative impact of adopting Topic 606 as of November 1, 2018 did not have a material impact to the Consolidated Financial Statements. The Company does not expect the impact of the adoption of Topic 606 to be material to the Consolidated Financial Statements on an ongoing basis. Accounting policy: A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and continues to primarily be recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2019 and October 31, 2018 were not material. However, for certain contracts related to the sale of customer-specific product within our Advanced Technology Systems segment, there was a change in revenue recognition upon adoption of the new revenue standard. Previously, these contracts were recognized at the point in time when the shipping terms were satisfied. Under the new revenue standard, we now recognize revenue for these contracts over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at July 31, 2019. Revenue recognized over time is not material to our overall Consolidated Financial Statements. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Sales, value add, and other taxes we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling, general and administrative expenses in our Consolidated Statements of Income. We offer assurance type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term. See Note 11 for details on our warranties. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, therefore, are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. See Note 12 for details on our operating segments.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 31, 2019
Inventory Disclosure [Abstract]
Schedule of Inventories	At July 31, 2019 and October 31, 2018, inventories consisted of the following: July 31, 2019 October 31, 2018 Raw materials and component parts $ 101,203 $ 112,823 Work-in-process 45,234 47,126 Finished goods 182,770 148,618 329,207 308,567 Obsolescence and other reserves (40,231 ) (37,545 ) LIFO reserve (6,362 ) (6,545 ) $ 282,614 $ 264,477

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Jul. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amount of Goodwill	Changes in the carrying amount of goodwill for the nine months ended July 31, 2019 by operating segment are as follows: Adhesive Dispensing Systems Advanced Technology Systems Industrial Coating Systems Total Balance at October 31, 2018 $ 388,991 $ 1,194,969 $ 24,058 $ 1,608,018 Acquisitions — 9,168 — 9,168 Currency effect (2,278 ) (1,432 ) — (3,710 ) Balance at July 31, 2019 $ 386,713 $ 1,202,705 $ 24,058 $ 1,613,476
Summary of Intangible Assets Subject to Amortization	Information regarding our intangible assets subject to amortization is as follows: July 31, 2019 Carrying Accumulated Amortization Net Customer relationships $ 479,033 $ 164,172 $ 314,861 Patent/technology costs 153,557 67,997 85,560 Trade name 96,910 39,575 57,335 Non-compete agreements 11,522 10,254 1,268 Other 1,399 1,396 3 Total $ 742,421 $ 283,394 $ 459,027 October 31, 2018 Carrying Accumulated Amortization Net Book Value Customer relationships $ 480,404 $ 137,640 $ 342,764 Patent/technology costs 153,602 59,845 93,757 Trade name 96,433 34,768 61,665 Non-compete agreements 11,469 9,919 1,550 Other 1,386 1,381 5 Total $ 743,294 $ 243,553 $ 499,741

Pension and Other Postretirem_2

Pension and Other Postretirement Plans (Tables)	9 Months Ended
	Jul. 31, 2019
Pension Cost [Member]
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Components of Net Periodic Benefits Cost	The components of net periodic pension cost for the three and nine months ended July 31, 2019 and 2018 were: U.S. International Three Months Ended 2019 2018 2019 2018 Service cost $ 3,740 $ 3,314 $ 484 $ 505 Interest cost 4,736 3,704 416 413 Expected return on plan assets (5,908 ) (5,491 ) (397 ) (379 ) Amortization of prior service credit (16 ) (5 ) (76 ) (80 ) Amortization of net actuarial loss 1,938 2,353 424 527 Total benefit cost $ 4,490 $ 3,875 $ 851 $ 986 U.S. International Nine Months Ended 2019 2018 2019 2018 Service cost $ 10,895 $ 9,940 $ 1,454 $ 1,532 Interest cost 13,726 11,113 1,262 1,257 Expected return on plan assets (17,506 ) (16,472 ) (1,204 ) (1,152 ) Amortization of prior service credit (46 ) (17 ) (228 ) (242 ) Amortization of net actuarial loss 5,026 7,059 1,280 1,604 Total benefit cost $ 12,095 $ 11,623 $ 2,564 $ 2,999
Postretirement Benefit Costs [Member]
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Components of Net Periodic Benefits Cost	The components of other postretirement benefit cost for the three and nine months ended July 31, 2019 and 2018 were: U.S. International Three Months Ended 2019 2018 2019 2018 Service cost $ 70 $ 172 $ 3 $ 5 Interest cost 698 627 3 5 Amortization of prior service credit (6 ) (24 ) — — Amortization of net actuarial (gain) loss 162 264 (5 ) (5 ) Total benefit cost $ 924 $ 1,039 $ 1 $ 5 U.S. International Nine Months Ended 2019 2018 2019 2018 Service cost $ 401 $ 528 $ 13 $ 15 Interest cost 2,195 1,922 15 15 Amortization of prior service credit (20 ) (74 ) — — Amortization of net actuarial (gain) loss 467 809 (22 ) (15 ) Total benefit cost $ 3,043 $ 3,185 $ 6 $ 15

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jul. 31, 2019
Equity [Abstract]
Summary of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss, including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated translation postretirement benefit other comprehensive adjustments plan adjustments loss Balance at October 31, 2018 $ (57,042 ) $ (122,272 ) $ (179,314 ) Amortization of prior service costs and net actuarial losses, net of tax of $(1,670) — 5,328 5,328 Foreign currency translation adjustments 227 — 227 Balance at July 31, 2019 $ (56,815 ) $ (116,944 ) $ (173,759 )

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summarized Activity Related to Stock Options	The following table summarizes activity related to stock options for the nine months ended July 31, 2019: Number of Options Weighted-Average Exercise Price Per Share Aggregate Intrinsic Value Weighted Average Remaining Term Outstanding at October 31, 2018 1,885 $ 85.33 Granted 348 $ 124.89 Exercised (289 ) $ 59.81 Forfeited or expired (21 ) $ 121.19 Outstanding at July 31, 2019 1,923 $ 95.92 $ 87,950 6.7 years Vested or expected to vest at July 31, 2019 1,907 $ 95.68 $ 87,671 6.7 years Exercisable at July 31, 2019 1,030 $ 78.98 $ 64,554 5.4 years
Fair Value Assumptions of Stock Options	The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine months ended July 31, 2019 July 31, 2018 Expected volatility 24.1%-24.5% 24.0%-26.7% Expected dividend yield 1.04% 0.97% Risk-free interest rate 2.84%-2.95% 2.09%-2.20% Expected life of the option (in years) 5.3-6.2 5.4-6.2
Summarized Activity Related to Restricted Stock	The following table summarizes activity related to restricted shares during the nine months ended July 31, 2019: Number of Shares Weighted-Average Grant Date Fair Value Restricted shares at October 31, 2018 53 $ 108.82 Granted 40 $ 131.19 Vested (26 ) $ 97.84 Restricted shares at July 31, 2019 67 $ 126.30
Summarized Activity Related to Restricted Stock Units	The following table summarizes activity related to restricted share units during the nine months ended July 31, 2019: Number of Units Weighted-Average Grant Date Fair Value Restricted share units at October 31, 2018 0 $ — Granted 8 $ 126.83 Restricted share units at July 31, 2019 8 $ 126.83
Summarized Activity Related to Director Deferred Compensation Shares	The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2019: Number of Shares Weighted-Average Grant Date Fair Value Outstanding at October 31, 2018 107 $ 51.24 Dividend equivalents 1 $ 128.35 Outstanding at July 31, 2019 108 $ 51.87

Warranties (Tables)

Warranties (Tables)	9 Months Ended
	Jul. 31, 2019
Guarantees [Abstract]
Reconciliation of Product Warranty Liability	Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2019 and 2018: July 31, 2019 July 31, 2018 Beginning balance at October 31 $ 12,195 $ 13,377 Accruals for warranties 7,628 8,440 Warranty payments (7,837 ) (9,358 ) Currency effect (78 ) 13 Ending balance $ 11,908 $ 12,472

Operating Segments (Tables)

Operating Segments (Tables)	9 Months Ended
	Jul. 31, 2019
Segment Reporting [Abstract]
Segments	The following table presents information about our segments: Adhesive Advanced Industrial Corporate Total Three months ended July 31, 2019 Net external sales $ 248,983 $ 253,098 $ 57,665 $ — $ 559,746 Operating profit (loss) 77,689 53,562 11,122 (12,097 ) 130,276 Three months ended July 31, 2018 Net external sales $ 244,728 $ 266,595 $ 69,920 $ — $ 581,243 Operating profit (loss) (1) 69,268 67,466 15,633 (14,825 ) 137,542 Nine months ended July 31, 2019 Net external sales $ 697,223 $ 736,850 $ 174,702 $ — $ 1,608,775 Operating profit (loss) 196,594 150,882 33,108 (37,131 ) 343,453 Nine months ended July 31, 2018 Net external sales $ 704,367 $ 789,135 $ 191,871 $ — $ 1,685,373 Operating profit (loss) (1) 193,595 193,649 38,228 (39,688 ) 385,784 (1)
Reconciliation of Segment Operating Income to Consolidated Income Before Income Taxes	A reconciliation of total segment operating income to total consolidated income before income taxes is as follows: Three Months Ended Nine Months Ended July 31, 2019 July 31, 2018 July 31, 2019 July 31, 2018 Total profit for reportable segments $ 130,276 $ 137,542 $ 343,453 $ 385,784 Interest expense (11,500 ) (13,765 ) (36,238 ) (37,210 ) Interest and investment income 511 356 1,153 865 Other-net 210 (1,438 ) (4,546 ) (5,107 ) Income before income taxes $ 119,497 $ 122,695 $ 303,822 $ 344,332
Sales and Long-lived Asset Information by Geographic Regions	We have significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2019 July 31, 2018 July 31, 2019 July 31, 2018 United States $ 190,460 $ 191,512 $ 551,510 $ 536,164 Americas 47,040 38,911 123,159 112,149 Europe 143,449 150,710 425,650 447,384 Japan 30,488 28,367 89,566 127,266 Asia Pacific 148,309 171,743 418,890 462,410 Total net external sales $ 559,746 $ 581,243 $ 1,608,775 $ 1,685,373

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jul. 31, 2019
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2019 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 4,254 $ — $ 4,254 $ — Total assets at fair value $ 4,254 $ — $ 4,254 $ — Liabilities: Deferred compensation plans (b) $ 11,610 $ — $ 11,610 $ — Foreign currency forward contracts (a) 3,197 — 3,197 — Total liabilities at fair value $ 14,807 $ — $ 14,807 $ — July 31, 2018 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 2,160 $ — $ 2,160 $ — Total assets at fair value $ 2,160 $ — $ 2,160 $ — Liabilities: Deferred compensation plans (b) $ 11,138 $ — $ 11,138 $ — Foreign currency forward contracts (a) 2,399 — 2,399 — Total liabilities at fair value $ 13,537 $ — $ 13,537 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable	The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. 2019 Carrying Amount Fair Value Long-term debt (including current portion) 1,348,606 1,371,640

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Jul. 31, 2019
Investments All Other Investments [Abstract]
Outstanding Currency, Forward Exchange Contracts	The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2019 and 2018: Notional Amounts July 31, 2019 contract amounts: Sell Buy Euro $ 219,910 $ 90,043 British pound 20,542 45,955 Japanese yen 32,560 48,670 Australian dollar 350 7,683 Hong Kong dollar 1,209 136,818 Singapore dollar 782 15,449 Others 3,460 63,388 Total $ 278,813 $ 408,006 Notional Amounts July 31, 2018 contract amounts: Sell Buy Euro $ 239,642 $ 201,296 British pound 41,649 70,644 Japanese yen 22,872 43,591 Australian dollar 185 7,729 Hong Kong dollar 453 118,507 Singapore dollar 613 12,820 Others 3,759 53,868 Total $ 309,173 $ 508,455

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Jul. 31, 2019
Debt Disclosure [Abstract]
Long-Term Debt	A summary of long-term debt is as follows: July 31, 2019 October 31, 2018 Revolving credit agreement, due 2024 $ — $ 52,200 Senior notes, due 2020-2025 140,800 156,700 Senior notes, due 2020-2027 92,857 100,000 Senior notes, due 2023-2030 350,000 350,000 Term loan, due 2020-2024 605,000 605,000 Euro loan, due 2021 127,396 16,967 Private shelf facility, due 2020 36,111 36,111 Development loans, due 2019-2026 985 1,086 1,353,149 1,318,064 Less current maturities 168,734 28,734 Less unamortized debt issuance costs 4,543 3,973 Long-term maturities $ 1,179,872 $ 1,285,357

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Significant Accounting Policies [Line Items]
Ownership percentage in affiliates and joint ventures	50.00%		50.00%
Stock Options [Member]
Significant Accounting Policies [Line Items]
Options for common shares excluded from computation of diluted earning per share	0	0	235,000	0

Recently Issued Accounting St_2

Recently Issued Accounting Standards - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 31, 2018	Jul. 31, 2018	Aug. 31, 2018
New Accounting Guidance Issued and Not Yet Adopted [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Defined benefit plan effect of percentage change in assumed health care cost trend rates			1.00%
Other Expense [Member] | Accounting Standards Update 2017-07 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reclassification due to change in accounting principles	$ 1,966	$ 5,780
Cost of Sales [Member] | Accounting Standards Update 2017-07 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reclassification due to change in accounting principles	(80)	(237)
Selling, General and Administrative Expenses [Member] | Accounting Standards Update 2017-07 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reclassification due to change in accounting principles	$ (1,886)	$ (5,543)

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands	Oct. 17, 2018	Jan. 02, 2018	Jul. 31, 2019	Jul. 31, 2018	Oct. 31, 2018
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired			$ 12,110	$ 45,364
Goodwill			$ 1,613,476		$ 1,608,018
Cladach Nua Teoranta [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Acquired percent of the outstanding shares	100.00%
Acquisition of businesses, net of cash acquired	$ 5,236
Acquisition of business, earn-out liability	1,131
Goodwill	3,776
Identifiable intangible assets	697
Cladach Nua Teoranta [Member] | Customer Relationships [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 58
Intangible assets amortization period	6 years
Cladach Nua Teoranta [Member] | Trade Names [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 70
Intangible assets amortization period	9 years
Cladach Nua Teoranta [Member] | Technology-Based Intangible Assets [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 499
Intangible assets amortization period	7 years
Cladach Nua Teoranta [Member] | Non-compete Agreements [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 70
Intangible assets amortization period	3 years
Sonoscan, Inc. [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Acquired percent of the outstanding shares		100.00%
Acquisition of businesses, net of cash acquired		$ 46,018
Goodwill		22,775
Identifiable intangible assets		7,910
Cash acquired from business acquisition		655
Sonoscan, Inc. [Member] | Customer Relationships [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 1,700
Intangible assets amortization period		7 years
Sonoscan, Inc. [Member] | Trade Names [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 3,300
Intangible assets amortization period		11 years
Sonoscan, Inc. [Member] | Technology-Based Intangible Assets [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 2,500
Intangible assets amortization period		7 years
Sonoscan, Inc. [Member] | Non-compete Agreements [Member] | 2018 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 410
Intangible assets amortization period		5 years

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands	Jul. 31, 2019	Oct. 31, 2018
Inventory Disclosure [Abstract]
Raw materials and component parts	$ 101,203	$ 112,823
Work-in-process	45,234	47,126
Finished goods	182,770	148,618
Inventories - gross	329,207	308,567
Obsolescence and other reserves	(40,231)	(37,545)
LIFO reserve	(6,362)	(6,545)
Inventories - net	$ 282,614	$ 264,477

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Summary of Changes in Carrying Amount of Goodwill (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2019USD ($)
Goodwill [Line Items]
Beginning balance	$ 1,608,018
Acquisitions	9,168
Currency effect	(3,710)
Ending balance	1,613,476
Adhesive Dispensing Systems [Member]
Goodwill [Line Items]
Beginning balance	388,991
Currency effect	(2,278)
Ending balance	386,713
Advanced Technology Systems [Member]
Goodwill [Line Items]
Beginning balance	1,194,969
Acquisitions	9,168
Currency effect	(1,432)
Ending balance	1,202,705
Industrial Coating Systems [Member]
Goodwill [Line Items]
Beginning balance	24,058
Ending balance	$ 24,058

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018	Oct. 31, 2018
Goodwill [Line Items]
Goodwill accumulated impairment loss	$ 232,789		$ 232,789		$ 232,789
Intangible assets, amortization expense	13,903	$ 14,036	41,665	$ 42,097
Advanced Technology Systems [Member]
Goodwill [Line Items]
Goodwill accumulated impairment loss	229,173		229,173		229,173
Industrial Coating Systems [Member]
Goodwill [Line Items]
Goodwill accumulated impairment loss	$ 3,616		$ 3,616		$ 3,616

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands	Jul. 31, 2019	Oct. 31, 2018
Finite Lived Intangible Assets [Line Items]
Carrying Amount	$ 742,421	$ 743,294
Accumulated Amortization	283,394	243,553
Net Book Value	459,027	499,741
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	479,033	480,404
Accumulated Amortization	164,172	137,640
Net Book Value	314,861	342,764
Patent/Technology Costs [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	153,557	153,602
Accumulated Amortization	67,997	59,845
Net Book Value	85,560	93,757
Trade Names [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	96,910	96,433
Accumulated Amortization	39,575	34,768
Net Book Value	57,335	61,665
Non-compete Agreements [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	11,522	11,469
Accumulated Amortization	10,254	9,919
Net Book Value	1,268	1,550
Other [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	1,399	1,386
Accumulated Amortization	1,396	1,381
Net Book Value	$ 3	$ 5

Pension and Other Postretirem_3

Pension and Other Postretirement Plans - Net Periodic Benefit Cost (Detail) - Pension Plans [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
United States [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 3,740	$ 3,314	$ 10,895	$ 9,940
Interest cost	4,736	3,704	13,726	11,113
Expected return on plan assets	(5,908)	(5,491)	(17,506)	(16,472)
Amortization of prior service credit	(16)	(5)	(46)	(17)
Amortization of net actuarial loss	1,938	2,353	5,026	7,059
Total benefit cost	4,490	3,875	12,095	11,623
International [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	484	505	1,454	1,532
Interest cost	416	413	1,262	1,257
Expected return on plan assets	(397)	(379)	(1,204)	(1,152)
Amortization of prior service credit	(76)	(80)	(228)	(242)
Amortization of net actuarial loss	424	527	1,280	1,604
Total benefit cost	$ 851	$ 986	$ 2,564	$ 2,999

Pension and Other Postretirem_4

Pension and Other Postretirement Plans - Other Postretirement Benefit Cost (Detail) - Postretirement Benefit Costs [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
United States [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 70	$ 172	$ 401	$ 528
Interest cost	698	627	2,195	1,922
Amortization of prior service credit	(6)	(24)	(20)	(74)
Amortization of net actuarial (gain) loss	162	264	467	809
Total benefit cost	924	1,039	3,043	3,185
International [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	3	5	13	15
Interest cost	3	5	15	15
Amortization of net actuarial (gain) loss	(5)	(5)	(22)	(15)
Total benefit cost	$ 1	$ 5	$ 6	$ 15

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2017	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018	Oct. 31, 2018
Income Tax [Line Items]
Effective tax rates		21.40%	22.70%	22.80%	15.60%
U.S. federal corporate income tax rate	35.00%			21.00%		23.30%
Provisional discrete tax (benefit) expense				$ 4,866	$ (22,089)
Discrete tax benefit		$ 210	$ 544	$ 3,227	$ 7,494
Favorable adjustment to unrecognized tax benefits		$ 858	$ 1,041
Maximum [Member]
Income Tax [Line Items]
Measurement period				1 year

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2019	Apr. 30, 2019	Jan. 31, 2019	Jul. 31, 2018	Apr. 30, 2018	Jan. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			$ (179,314)				$ (179,314)
Amortization of prior service cost and net actuarial losses, net of tax	$ 2,378			$ 2,796			5,328	$ 7,118
Foreign currency translation adjustments	(7,172)	$ (9,064)	16,463	$ (26,361)	$ (19,284)	$ 38,582	227	$ (7,063)
Accumulated other comprehensive loss, Ending balance	(173,759)						(173,759)
Cumulative Translation Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			(57,042)				(57,042)
Foreign currency translation adjustments							227
Accumulated other comprehensive loss, Ending balance	(56,815)						(56,815)
Pension And Postretirement Benefit Plan Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			$ (122,272)				(122,272)
Amortization of prior service cost and net actuarial losses, net of tax							5,328
Accumulated other comprehensive loss, Ending balance	$ (116,944)						$ (116,944)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2019USD ($)
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Amortization of prior service costs and net actuarial losses, tax	$ 1,670

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of common shares available for grant	4,525		4,525
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%
Directors [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expense related to director deferred compensation	$ 38	$ 31	$ 113	$ 92
Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum rate of stock option, description			not exceeding 25 percent per year
Option expiring period			10 years
Compensation expense recognized	2,525	2,479	$ 7,583	$ 7,550
Options exercisable beginning period			1 year
Normal retirement age			65 years
Period for options considered to be forfeited for retirees			12 months
Termination period on death or disability of option holder			12 months
Options grants in period vesting period			Dec. 28, 2017
Unrecognized compensation cost related to unvested stock option	10,551		$ 10,551
Weighted average period expected to be amortized, non vested shares			1 year 4 months 24 days
Weighted-average expected volatility used			24.30%	25.00%
Weighted average grant date fair value of stock options granted			$ 31.74	$ 31.42
Total intrinsic value of options exercised	2,449	2,971	$ 21,770	$ 32,715
Cash received from the exercise of stock options			$ 17,275	17,352
Stock Options [Member] | Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum rate of stock option			25.00%
Restricted Shares and Restricted Share Units [Member] | Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant restricted shares transferred period			3 years
Restricted Shares and Restricted Share Units [Member] | Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant restricted shares transferred period			1 year
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Normal retirement age			65 years
Weighted average period expected to be amortized, non vested shares			1 year 9 months 18 days
Period for restricted shares and share units considered to be forfeited for retirees			12 months
Restricted shares termination period for disability or death			12 months
Restriction period for restricted shares granted			Dec. 28, 2017
Unrecognized compensation cost related to nonvested restricted stock	5,505		$ 5,505
Expense related to nonvested common shares	898	644	2,762	2,035
Common share dividends amount included in compensation cost	22	17	$ 58	51
Restricted Stock Unit [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average period expected to be amortized, non vested shares			3 months 18 days
Period for pro-rata vesting of shares or units for non-employee directors			1 year
Unrecognized compensation cost related to nonvested restricted stock	260		$ 260
Expense related to nonvested common shares	263	253	$ 789	$ 758
Performance Share Incentive Awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value			$ 120.12	$ 123.45
Compensation expense	15	942	$ 1,611	$ 5,928
Cumulative amount recorded in shareholders' equity related to Long-Term Incentive Plan	9,080		$ 9,080
Periods of performance considered for calculating compensation expense			3 years
Performance Share Incentive Awards [Member] | November 28, 2016 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value					$ 104.49
Performance Share Incentive Awards [Member] | November 21, 2016 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value					$ 103.75
Deferred Compensation [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common share dividends amount included in compensation cost	$ 74	$ 67	$ 219	$ 201
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%

Stock-Based Compensation - Summ

Stock-Based Compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options [Member] $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Jul. 31, 2019USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning balance | shares	1,885
Number of Options, Granted | shares	348
Number of Options, Exercised | shares	(289)
Number of Options, Forfeited or expired | shares	(21)
Number of Options, Outstanding, Ending balance | shares	1,923
Number of Options, Vested or expected to vest | shares	1,907
Number of Options, Exercisable | shares	1,030
Weighted-Average Exercise Price Per Share, Outstanding, Beginning balance | $ / shares	$ 85.33
Weighted-Average Exercise Price Per Share, Granted | $ / shares	124.89
Weighted-Average Exercise Price Per Share, Exercised | $ / shares	59.81
Weighted-Average Exercise Price Per Share, Forfeited or expired | $ / shares	121.19
Weighted-Average Exercise Price Per Share, Outstanding, Ending balance | $ / shares	95.92
Weighted-Average Exercise Price Per Share, Vested or expected to vest | $ / shares	95.68
Weighted-Average Exercise Price Per Share, Exercisable | $ / shares	$ 78.98
Aggregate Intrinsic Value, Outstanding | $	$ 87,950
Aggregate Intrinsic Value, Vested or expected to vest | $	87,671
Aggregate Intrinsic Value, Exercisable | $	$ 64,554
Weighted Average Remaining Term, Outstanding	6 years 8 months 12 days
Weighted Average Remaining Term, Vested or expected to vest	6 years 8 months 12 days
Weighted Average Remaining Term, Exercisable	5 years 4 months 24 days

Stock-Based Compensation - Fair

Stock-Based Compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options [Member]	9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, Minimum	24.10%	24.00%
Expected volatility, Maximum	24.50%	26.70%
Expected dividend yield	1.04%	0.97%
Risk-free interest rate, Minimum	2.84%	2.09%
Risk-free interest rate, Maximum	2.95%	2.20%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of the option (in years)	5 years 3 months 18 days	5 years 4 months 24 days
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of the option (in years)	6 years 2 months 12 days	6 years 2 months 12 days

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summarized Activity Related to Restricted Stock (Detail) - Restricted Stock [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2019$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Restricted Shares, Beginning balance | shares	53
Number of Restricted Shares, Granted | shares	40
Number of Restricted Shares, Vested | shares	(26)
Number of Restricted Shares, Ending balance | shares	67
Weighted-Average Grant Date Fair Value, Restricted Shares, Beginning balance | $ / shares	$ 108.82
Weighted-Average Grant Date Fair Value, Granted | $ / shares	131.19
Weighted-Average Grant Date Fair Value, Vested | $ / shares	97.84
Weighted-Average Grant Date Fair Value, Restricted Shares, Ending balance | $ / shares	$ 126.30

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2019$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Restricted Shares, Beginning balance	0
Number of Restricted Share Units, Granted	8
Number of Restricted Shares, Ending balance	8
Weighted-Average Grant Date Fair Value, Granted | $ / shares	$ 126.83
Weighted-Average Grant Date Fair Value, Restricted Shares, Ending balance | $ / shares	$ 126.83

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors [Member] - Deferred Compensation Share Equivalent Units [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2019$ / sharesshares
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Number of Shares, Outstanding, Beginning balance | shares	107
Number of Shares, Dividend equivalents | shares	1
Number of Shares, Outstanding, Ending balance | shares	108
Weighted-Average Grant Date Fair Value, Beginning balance | $ / shares	$ 51.24
Weighted-Average Grant Date Fair Value, Dividend equivalents | $ / shares	128.35
Weighted-Average Grant Date Fair Value, Ending balance | $ / shares	$ 51.87

Warranties - Additional Informa

Warranties - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2019
Guarantees [Abstract]
Product warranty period	1 year

Warranties - Reconciliation of

Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018
Guarantees [Abstract]
Beginning balance at October 31	$ 12,195	$ 13,377
Accruals for warranties	7,628	8,440
Warranty payments	(7,837)	(9,358)
Currency effect	(78)	13
Ending balance	$ 11,908	$ 12,472

Operating Segments - Additional

Operating Segments - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2019Segment
Segment Reporting [Abstract]
Number of operating segments	3

Operating Segments - Segments (

Operating Segments - Segments (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018		Jul. 31, 2019	Jul. 31, 2018
Segment Reporting Information [Line Items]
Net external sales	$ 559,746	$ 581,243		$ 1,608,775	$ 1,685,373
Operating profit (loss)	130,276	137,542		343,453	385,784
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net external sales	559,746	581,243		1,608,775	1,685,373
Operating profit (loss)	130,276	137,542	[1]	343,453	385,784	[1]
Operating Segments [Member] | Adhesive Dispensing Systems [Member]
Segment Reporting Information [Line Items]
Net external sales	248,983	244,728		697,223	704,367
Operating profit (loss)	77,689	69,268	[1]	196,594	193,595	[1]
Operating Segments [Member] | Advanced Technology Systems [Member]
Segment Reporting Information [Line Items]
Net external sales	253,098	266,595		736,850	789,135
Operating profit (loss)	53,562	67,466	[1]	150,882	193,649	[1]
Operating Segments [Member] | Industrial Coating Systems [Member]
Segment Reporting Information [Line Items]
Net external sales	57,665	69,920		174,702	191,871
Operating profit (loss)	11,122	15,633	[1]	33,108	38,228	[1]
Corporate [Member]
Segment Reporting Information [Line Items]
Operating profit (loss)	$ (12,097)	$ (14,825)	[1]	$ (37,131)	$ (39,688)	[1]
[1]

Operating Segments - Reconcilia

Operating Segments - Reconciliation of Segment Operating Income to Consolidated Income Before Income Taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Segment Reporting [Abstract]
Total profit for reportable segments	$ 130,276	$ 137,542	$ 343,453	$ 385,784
Interest expense	(11,500)	(13,765)	(36,238)	(37,210)
Interest and investment income	511	356	1,153	865
Other - net	210	(1,438)	(4,546)	(5,107)
Income before income taxes	$ 119,497	$ 122,695	$ 303,822	$ 344,332

Operating Segments - Sales Info

Operating Segments - Sales Information by Geographic Regions (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Net external sales
Net external sales	$ 559,746	$ 581,243	$ 1,608,775	$ 1,685,373
United States [Member]
Net external sales
Net external sales	190,460	191,512	551,510	536,164
Americas [Member]
Net external sales
Net external sales	47,040	38,911	123,159	112,149
Europe [Member]
Net external sales
Net external sales	143,449	150,710	425,650	447,384
Japan [Member]
Net external sales
Net external sales	30,488	28,367	89,566	127,266
Asia Pacific [Member]
Net external sales
Net external sales	$ 148,309	$ 171,743	$ 418,890	$ 462,410

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring [Member] - USD ($) $ in Thousands		Jul. 31, 2019	Jul. 31, 2018
Assets:
Foreign currency forward contracts	[1]	$ 4,254	$ 2,160
Total assets at fair value		4,254	2,160
Liabilities:
Deferred compensation plans	[2]	11,610	11,138
Foreign currency forward contracts	[1]	3,197	2,399
Total liabilities at fair value		14,807	13,537
Level 2 [Member]
Assets:
Foreign currency forward contracts	[1]	4,254	2,160
Total assets at fair value		4,254	2,160
Liabilities:
Deferred compensation plans	[2]	11,610	11,138
Foreign currency forward contracts	[1]	3,197	2,399
Total liabilities at fair value		$ 14,807	$ 13,537
[1]	We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.
[2]	Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Parenthetical) (Detail)	9 Months Ended
	Jul. 31, 2019
Fair Value Disclosures [Abstract]
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90.00%

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) $ in Thousands	Jul. 31, 2019USD ($)
Schedule Of Carrying Amounts And Fair Values Of Financial Instruments [Abstract]
Long-term debt (including current portion), Carrying Amount	$ 1,348,606
Long-term debt (including current portion), Fair Value	$ 1,371,640

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Maturity of foreign currency forward contracts			90 days
Gains (losses) on foreign currency forward contracts	$ 975	$ 2,042	$ 769	$ (529)
Gains (losses) in fair value of balance sheet positions denominated in foreign currencies	$ 407	$ (1,152)	$ 267	$ 451

Derivative Financial Instrume_4

Derivative Financial Instruments - Outstanding Currency, Forward Exchange Contracts (Detail) - Foreign Currency Forward Contracts [Member] - USD ($) $ in Thousands	Jul. 31, 2019	Jul. 31, 2018
Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 278,813	$ 309,173
Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	408,006	508,455
Euro [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	219,910	239,642
Euro [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	90,043	201,296
British Pound [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	20,542	41,649
British Pound [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	45,955	70,644
Japanese Yen [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	32,560	22,872
Japanese Yen [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	48,670	43,591
Australian Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	350	185
Australian Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	7,683	7,729
Hong Kong Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	1,209	453
Hong Kong Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	136,818	118,507
Singapore Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	782	613
Singapore Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	15,449	12,820
Others [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	3,460	3,759
Others [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 63,388	$ 53,868

Long-Term Debt - Long-Term Debt

Long-Term Debt - Long-Term Debt (Detail) - USD ($) $ in Thousands	Jul. 31, 2019	Oct. 31, 2018
Debt Instrument [Line Items]
Revolving credit agreement, due 2024		$ 52,200
Private shelf facility, due 2020	$ 36,111	36,111
Development loans, due 2019-2026	985	1,086
Long-term Debt	1,353,149	1,318,064
Less current maturities	168,734	28,734
Less unamortized debt issuance costs	4,543	3,973
Long-term maturities	1,179,872	1,285,357
Senior Notes, Due 2020-2025 [Member]
Debt Instrument [Line Items]
Senior notes	140,800	156,700
Senior Notes, Due 2020-2027 [Member]
Debt Instrument [Line Items]
Senior notes	92,857	100,000
Senior Notes, Due 2023-2030 [Member]
Debt Instrument [Line Items]
Senior notes	350,000	350,000
Term Loan, Due 2020-2024 [Member]
Debt Instrument [Line Items]
Term loan	605,000	605,000
Euro Loan, Due 2021 [Member]
Debt Instrument [Line Items]
Euro loan	$ 127,396	$ 16,967

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Detail) € in Thousands

Jun. 30, 2018USD ($)

Oct. 31, 2011

Apr. 30, 2019USD ($)

Jun. 30, 2018USD ($)

Jul. 31, 2015USD ($)

Jul. 31, 2019USD ($)

Oct. 31, 2016USD ($)

Oct. 31, 2015USD ($)

Oct. 31, 2012USD ($)

Jul. 31, 2019EUR (€)

Oct. 31, 2018USD ($)

Oct. 31, 2018EUR (€)

Debt Instrument [Line Items]

Outstanding balance

$ 52,200,000

Outstanding balance

$ 36,111,000

36,111,000

Term loan facility

$ 1,348,606,000

Revolving Credit Agreement [Member]

Debt Instrument [Line Items]

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019, and the amount we could borrow under the facility would not have been limited by any debt covenants.

Revolving credit facility expiration

2024-04

Revolving credit facility

$ 850,000,000

Credit facility, term

5 years

Outstanding balance

$ 0

52,200,000

Revolving Credit Agreement [Member] | Swing Line Loans [Member]

Debt Instrument [Line Items]

Revolving credit facility

$ 75,000,000

Syndicated Revolving Credit Agreement [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2020-02

Three-year Note Purchase and Private Shelf Agreement [Member]

Debt Instrument [Line Items]

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019, and the amount we could borrow would not have been limited by any debt covenants.

Debt instrument, face amount

$ 150,000,000

Period of agreement

3 years

Maximum credit facility

$ 200,000,000

$ 180,000,000

Maximum life of borrowings

12 years

Maximum average life of borrowings

10 years

Outstanding balance

$ 36,111,000

36,111,000

Three-year Note Purchase and Private Shelf Agreement [Member] | Minimum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2020-01

Three-year Note Purchase and Private Shelf Agreement [Member] | Maximum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2020-09

Term Loan Facility [Member] | Group of Banks [Member]

Debt Instrument [Line Items]

Term loan

$ 605,000,000

Weighted average interest rate for borrowings

2.98%

2.98%

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019.

Term Loan Due in March 2020 [Member] | Group of Banks [Member]

Debt Instrument [Line Items]

Term loan

100,000,000

Term Loan Due in September 2022 [Member] | Group of Banks [Member]

Debt Instrument [Line Items]

Term loan

200,000,000

Term Loan Due in March 2024 [Member] | Group of Banks [Member]

Debt Instrument [Line Items]

Term loan

$ 305,000,000

Euro Loan, Due 2021 [Member]

Debt Instrument [Line Items]

Euro loan

$ 127,396,000

16,967,000

Euro Loan, Due 2021 [Member] | Bank of America [Member]

Debt Instrument [Line Items]

Weighted average interest rate for borrowings

1.00%

1.00%

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019.

Debt instrument, face amount | €

€ 150,000

Euro loan

$ 127,396,000

€ 115,000

Senior Notes, Due 2023-2030 [Member]

Debt Instrument [Line Items]

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019.

Debt instrument, face amount

$ 350,000,000

$ 350,000,000

Repayments of outstanding balance under syndicated revolving credit facility

$ 315,000,000

Outstanding balance

$ 350,000,000

350,000,000

Senior Notes, Due 2023-2030 [Member] | Minimum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2023-06

Debt instrument, fixed interest rates

3.71%

3.71%

Senior Notes, Due 2023-2030 [Member] | Maximum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2030-06

Debt instrument, fixed interest rates

4.17%

4.17%

Note A and B [Member] | Three-year Note Purchase and Private Shelf Agreement [Member] | Minimum [Member]

Debt Instrument [Line Items]

Debt instrument, fixed interest rates

2.21%

2.21%

Note C [Member] | Three-year Note Purchase and Private Shelf Agreement [Member] | Maximum [Member]

Debt Instrument [Line Items]

Debt instrument, fixed interest rates

2.56%

2.56%

Senior Notes, Due 2020-2025 [Member]

Debt Instrument [Line Items]

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019.

Debt instrument, face amount

$ 200,000,000

Outstanding balance

$ 140,800,000

156,700,000

Senior Notes, Due 2020-2025 [Member] | Minimum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2020-07

Debt instrument, fixed interest rates

2.62%

Senior Notes, Due 2020-2025 [Member] | Maximum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2025-07

Debt instrument, fixed interest rates

3.13%

Senior Notes, Due 2020-2027 [Member]

Debt Instrument [Line Items]

Outstanding balance

92,857,000

100,000,000

Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member]

Debt Instrument [Line Items]

Debt instrument, covenant compliance description

We were in compliance with all covenants at July 31, 2019.

Outstanding balance

$ 92,857,000

$ 100,000,000

Term loan facility

$ 100,000,000

Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member] | Minimum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2020-07

Debt instrument, fixed interest rates

2.89%

Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member] | Maximum [Member]

Debt Instrument [Line Items]

Revolving credit facility expiration

2027-07

Debt instrument, fixed interest rates

3.19%